Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. (IDRA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · IDRA · as of Dec 31, 2022
Ownership Breakdown
29
Institutional Holders
▲ 1 vs Q3
$1.10M
Total Inst. Value
▼ $168,161 vs Q3
—
Shares Outstanding
3.14M
13F Shares Held
▼ 246,952 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
IDRA largest shareholders · institutional ownership
Q4 2022 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
SIMPLEX TRADING, LLC biological products, (no diagnostic substances) | 2.3K | 6.98% | 6.98% | $0 | Feb 2, 2023 | NEW |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 1.27M | 1.70% | 1.70% | $443.72M | Feb 10, 2023 | ▲ 932 |
JPMORGAN CHASE & CO biological products, (no diagnostic substances) | 200 | 0.61% | 0.61% | $0 | Feb 13, 2023 | — held |
BLACKROCK INC. biological products, (no diagnostic substances) | 439.5K | 0.59% | 0.59% | $153.81M | Feb 13, 2023 | ▼ 185 |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 396.9K | 0.53% | 0.53% | $138.00M | Feb 13, 2023 | ▼ 932 |
CREDIT AGRICOLE S A biological products, (no diagnostic substances) | 200.0K | 0.27% | 0.27% | $70.00M | Feb 13, 2023 | — held |
HOLLENCREST CAPITAL MANAGEMENT biological products, (no diagnostic substances) | 129.0K | 0.17% | 0.17% | $45.15M | Feb 7, 2023 | — held |
STATE STREET CORP biological products, (no diagnostic substances) | 109.7K | 0.15% | 0.15% | $38.41M | May 15, 2023 | — held |
MORGAN STANLEY biological products, (no diagnostic substances) | 105.5K | 0.14% | 0.14% | $36.92M | Feb 14, 2023 | ▲ 13.9K |
NORTHERN TRUST CORP biological products, (no diagnostic substances) | 74.3K | 0.10% | 0.10% | $25.99M | Feb 13, 2023 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2022 vs prior quarter
Q4 2022
7
Increased
+86.3K shares9
New Positions
first time holders4
Decreased
−127.1K shares8
Sold Out
fully exitedNet shares change (top 50)
40.8K
+86.3K / −127.1K
Net new holders
+4
9 new / 8 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
IDRA insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
4
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
GOWEN MAXINE director | Aug 10, 2023 | Sale | 51 | $0.51 | $26.01 | 0 | Form 4 ↗ |
MILANO VINCENT director | Aug 10, 2023 | Sale | 3,283 | $0.53 | $1.8K | 9.0K | Form 4 ↗ |
Pillar Invest Corp 10 percent owner | May 17, 2023 | Purchase | 26,965 | $1.42 | $38.3K | 170.7K | Form 4 ↗ |
Pillar Invest Corp 10 percent owner | Jul 12, 2023 | Sale | 3,605 | $1.58 | $5.7K | 167.1K | Form 4 ↗ |
Pillar Invest Corp 10 percent owner | Jul 13, 2023 | Sale | 2,213 | $1.54 | $3.4K | 164.9K | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 6,887 | $1.40 | $9.6K | 1.33M | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 6,645 | $1.41 | $9.4K | 1.33M | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 8,469 | $1.42 | $12.0K | 1.32M | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 1,220 | $1.43 | $1.7K | 1.32M | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 3,369 | $1.44 | $4.9K | 1.31M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Idera Pharmaceuticals, Inc. (IDRA) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
The largest institutional shareholder of Idera Pharmaceuticals, Inc. is SIMPLEX TRADING, LLC, holding approximately 2,274 shares — equal to 6.98% of outstanding shares — as of December 31, 2022.
A total of 29 institutional investors currently hold IDRA stock, with a combined institutional value of approximately $1,099,615 as of the most recent 13F filing period.
Frequently asked questions
IDRA ownershipIdera Pharmaceuticals, Inc. (IDRA) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is SIMPLEX TRADING, LLC with a 6.98% stake. Company insiders hold —. Data sourced from SEC Form 13F as of December 31, 2022.